Allianceberstein Holding L.P. Press Releases

AB 
$27.23
*  
0.01
0.04%
Get AB Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading AB now
Exchange: NYSE
Industry: Finance
Community Rating:
View:    AB Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
AB Science: Web conference on masitinib in asthma - Safety and Efficacy Update
11/25/2014 11:55:00 AM - GlobeNewswire


AllianceBernstein Announces October 31, 2014 Assets Under Management
11/14/2014 8:20:00 AM - PR Newswire
▲0.85 % Price Change since this news event. The Volume Ratio is 4.98.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AB Science: The Data and Safety Monitoring Board recommends the continuation of the phase 2 study with masitinib in advanced hepatocellular carcinoma
11/12/2014 11:50:00 AM - GlobeNewswire


AB Science: Masitinib in Mastocytosis - Summary of Web Conference
11/10/2014 2:32:00 AM - GlobeNewswire


Peter S. Kraus, Chairman and Chief Executive Officer, to Participate in the Bank of America Merrill Lynch 2014 Banking & Financial Services Conference on November 12
11/5/2014 12:16:00 PM - PR Newswire
▲3.93 % Price Change since this news event. The Volume Ratio is 0.47.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AB Science : Web conference on Masitinib in mastocytosis
10/31/2014 12:52:00 PM - GlobeNewswire


AB Science: publication of preclinical data on the neuroprotective effect of masitinib
10/30/2014 1:13:00 PM - GlobeNewswire


AllianceBernstein Holding L.P. Announces Third Quarter Results
10/23/2014 7:10:00 AM - PR Newswire
▲6.58 % Price Change since this news event. The Volume Ratio is 1.83.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AllianceBernstein Expands its Liquid Alternatives Platform with Three New Funds: Credit Long/Short, Multi-Manager Alternative Strategies and Long/Short Multi-Manager
10/15/2014 11:06:00 AM - PR Newswire
▲18.34 % Price Change since this news event. The Volume Ratio is 3.05.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AllianceBernstein Announces September 30, 2014 Assets Under Management
10/10/2014 8:40:00 AM - PR Newswire
▲8.40 % Price Change since this news event. The Volume Ratio is 1.8.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AllianceBernstein to Report Third Quarter 2014 Results on Thursday, October 23, 2014
10/9/2014 11:36:00 AM - PR Newswire


AllianceBernstein to Report Third Quarter 2014 Results on Thursday, October 23, 2014
10/9/2014 11:36:00 AM - PR Newswire
▲7.88 % Price Change since this news event. The Volume Ratio is 1.04.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mark Brown, Franchesca Maddalena and Heather Balley Join AllianceBernstein''s Expanding Defined Contribution Team to Support its Business Development and Marketing Efforts
9/24/2014 10:36:00 AM - PR Newswire


Mark Brown, Franchesca Maddalena and Heather Balley Join AllianceBernstein's Expanding Defined Contribution Team to Support its Business Development and Marketing Efforts
9/24/2014 10:36:00 AM - PR Newswire


AllianceBernstein Announces August 31, 2014 Assets Under Management
9/11/2014 4:22:00 PM - PR Newswire